The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review
BACKGROUND: Cholangiocarcinoma and gallbladder cancer are difficult to treat curatively. The treatment of choice is surgery, dependent on detection at a resectable stage. No chemotherapy or radiotherapy options have shown substantial activity. Gemcitabine has demonstrated response in similar cancers...
Saved in:
Main Authors: | Brian H Dingle, R Bryan Rumble, Melissa C Brouwers |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/2005/565479 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
by: Jiandong Li, et al.
Published: (2025-02-01) -
Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report
by: Shuangying Zhao, et al.
Published: (2025-01-01) -
Enhanced expression of ten‐eleven translocation 1 reverses gemcitabine resistance in cholangiocarcinoma accompanied by a reduction in P‐glycoprotein expression
by: Chuanxu Wang, et al.
Published: (2019-03-01) -
The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer.
by: Farshid Maleki, et al.
Published: (2025-01-01) -
The role of mitochondrial dysfunction in the cytotoxic synergistic effect of gemcitabine and arsenic on breast cancer
by: Farshid Maleki, et al.
Published: (2025-01-01)